東方集團(600811.SH):籌劃購買輝瀾公司70%以上股權及債權事項 明起停牌
格隆匯6月29日丨東方集團(600811.SH)公佈,公司正在籌劃通過發行股份及支付現金方式購買東方集團有限公司持有的輝瀾投資有限公司(“輝瀾公司”)70%以上股權及債權。本次交易預計構成《上市公司重大資產重組管理辦法》規定的重大資產重組,亦構成關聯交易。本次交易不會導致公司實際控制人發生變更。
鑑於有關事項尚處於籌劃階段,存在不確定性,為保證公平信息披露並維護投資者利益,避免造成股票價格異常波動,經向上海證券交易所申請,公司股票自2021年6月30日(週三)開市起停牌,預計停牌時間不超過10個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.